1-25 of 51 Products & Services
This kit is designed to assess binding and inhibition of human PCSK9 and LDLR, using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapetics using competition assays.
This is a replacement for AL3119.
1-22 of 22 Business Insights